Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene plus EGFR-TKIs in advanced NSCLC
NCT04401059Phase 4Recruiting
- Start
- Nov 2020
- Primary completion
- Sep 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Elemene in non-small cell lung cancer (NSCLC). Started Nov 2020; status: recruiting.
02
Drugs
Elemene
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04401059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401059.